These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27738106)

  • 1. Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α.
    Hinds TD; Burns KA; Hosick PA; McBeth L; Nestor-Kalinoski A; Drummond HA; AlAmodi AA; Hankins MW; Vanden Heuvel JP; Stec DE
    J Biol Chem; 2016 Nov; 291(48):25179-25191. PubMed ID: 27738106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?
    Hinds TD; Adeosun SO; Alamodi AA; Stec DE
    Med Hypotheses; 2016 Oct; 95():54-57. PubMed ID: 27692168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation.
    Gordon DM; Adeosun SO; Ngwudike SI; Anderson CD; Hall JE; Hinds TD; Stec DE
    Arch Biochem Biophys; 2019 Sep; 672():108072. PubMed ID: 31422074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].
    Shi HB; Shi HL; Zhang XY; Chen DX; Duan ZP; Ren F
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):211-216. PubMed ID: 28482409
    [No Abstract]   [Full Text] [Related]  

  • 5. Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα.
    Hinds TD; Hosick PA; Chen S; Tukey RH; Hankins MW; Nestor-Kalinoski A; Stec DE
    Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E244-E252. PubMed ID: 28096081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
    Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
    J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance.
    Chen W; Tumanov S; Fazakerley DJ; Cantley J; James DE; Dunn LL; Shaik T; Suarna C; Stocker R
    Redox Biol; 2021 Nov; 47():102152. PubMed ID: 34610553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of miR-30a-3p Attenuates Hepatic Steatosis in Non-alcoholic Fatty Liver Disease.
    Wang DR; Wang B; Yang M; Liu ZL; Sun J; Wang Y; Sun H; Xie LJ
    Biochem Genet; 2020 Oct; 58(5):691-704. PubMed ID: 32419060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
    Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
    Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α.
    Marino JS; Stechschulte LA; Stec DE; Nestor-Kalinoski A; Coleman S; Hinds TD
    J Biol Chem; 2016 Dec; 291(50):25776-25788. PubMed ID: 27784782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of Peroxisome Proliferator-Activated Receptor α in Bitter Melon Seed Oil-Corrected Lipid Disorders and Conversion of α-Eleostearic Acid into Rumenic Acid in C57BL/6J Mice.
    Chang YY; Su HM; Chen SH; Hsieh WT; Chyuan JH; Chao PM
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliverdin Reductase A (BVRA) Knockout in Adipocytes Induces Hypertrophy and Reduces Mitochondria in White Fat of Obese Mice.
    Stec DE; Gordon DM; Nestor-Kalinoski AL; Donald MC; Mitchell ZL; Creeden JF; Hinds TD
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32131495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of aldose reductase ameliorates diet-induced nonalcoholic steatohepatitis in mice via modulating the phosphorylation of hepatic peroxisome proliferator-activated receptor α.
    Chen T; Shi D; Chen J; Yang Y; Qiu M; Wang W; Qiu L
    Mol Med Rep; 2015 Jan; 11(1):303-8. PubMed ID: 25333350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.
    Zhao X; Xue J; Wang XL; Zhang Y; Deng M; Xie ML
    Int Immunopharmacol; 2014 Sep; 22(1):176-81. PubMed ID: 24993341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease.
    Pawlak M; Lefebvre P; Staels B
    J Hepatol; 2015 Mar; 62(3):720-33. PubMed ID: 25450203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycogen synthase kinase 3β promotes autophagy to protect mice from acute liver failure mediated by peroxisome proliferator-activated receptor α.
    Ren F; Zhang L; Zhang X; Shi H; Wen T; Bai L; Zheng S; Chen Y; Chen D; Li L; Duan Z
    Cell Death Dis; 2016 Mar; 7(3):e2151. PubMed ID: 27010852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliverdin reductase and bilirubin in hepatic disease.
    Weaver L; Hamoud AR; Stec DE; Hinds TD
    Am J Physiol Gastrointest Liver Physiol; 2018 Jun; 314(6):G668-G676. PubMed ID: 29494209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of the biliverdin reductase-a gene is associated with increased endogenous oxidative stress.
    Chen W; Maghzal GJ; Ayer A; Suarna C; Dunn LL; Stocker R
    Free Radic Biol Med; 2018 Feb; 115():156-165. PubMed ID: 29195835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
    Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
    Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.